retatrutide trial results news today New weight-loss drug showing stronger than current options Retatrutide for weight loss: Study

The Next Wave: Emerging GLP-1 Options for 2026 and Beyond The future of weight loss medications looks promising, with advanced GLP-1-based therapies either in late-stage clinical trials or awaiting approval or market launch

Precision matters when you are working with formulations where small volume changes equal significant dose changes

Protein matters too

This led to higher levels of cyclin D1, a protein crucial for promoting cell proliferation, suggesting a potential pathway for GLP-1RAs to increase risk for PDAC in humans

A randomised controlled trial of exenatide once-weekly in alcohol use disorder showed mixed results overall, with possible effects in certain subgroups

It offers compounded semaglutide and tirzepatide through a physician-guided process, delivered to your door on a monthly or quarterly basis